You have technical questions or need support for your physical security installation?
You want to access technical documentation and software downloads for our physical security products?
Thanks to the simple setup, high scalability and customizable architecture of Qognify VMS, Boehringer can create new CCTV installations significantly faster, reducing the total cost, time and effort of deployment projects.
These IT launches also include physical security applications — in particular, video management. Because Boehringer’s sites are numerous and widely spread out, it was a challenge to implement a video management system (VMS) that could support end users by meeting their requirements while simultaneously satisfying the IT needs of stability and ease of support.
To find the right VMS — one that would meet all its current and future requirements — Boehringer conducted an in-depth vendor selection process, pitting the market leaders in VMS against each other. They were compared via answers to more than 200 questions relating to IT security, system expandability, reliability of operation and ease of deployment, followed by physical testing conducted by end users and a technical team.
As a result of this thorough process, Qognify VMS solutions were selected as ideal for Boehringer’s multisite enterprise environments. With a focus on easy installation, configuration and management and support for the majority of network cameras available on the market, Qognify VMS is capable of managing all of Boehringer’s camera feeds. This allows Boehringer to exploit holistic video monitoring at a glance — whether on-site or remotely.
Thanks to the simple setup, high scalability and customizable architecture of Qognify VMS, Boehringer can create new CCTV installations significantly faster, reducing the total cost, time and effort of deployment projects. In addition, because Qognify VMS can be personalized to suit each customer’s and location’s particular needs, Boehringer was able to build the system to meet its exact specifications.
Boehringer is working on breakthrough therapies to improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family owned ever since, Boehringer has a long term perspective. Around 52,000 employees serve more than 130 markets in its three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
